Researchers at the University of Miami have found that an
over-the-counter supplement is effective in both preventing and treating
prostate cancer.
The supplement, 4-methylumbelliferone (4-MU), is a non-toxic oral
agent used as a dietary supplement in Europe and Asia for improving
liver health. Treating mice with the supplement appeared to inhibit
prostate cancer from further developing starting as soon as eight weeks
after the rodents were diagnosed.
“The results were simply amazing,” principal investigator Vinata B.
Lokeshwar, a professor of urology and director of the pilot and
translational studies component of the Miami Clinical and Translational
Science Institute, said in a news release.
The team also found that 4-MU halted the metastatic spread of prostate cancer.
No comments:
Post a Comment